4,229
Views
131
CrossRef citations to date
0
Altmetric
Review

New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance

, &
Pages 423-432 | Published online: 09 Jan 2014

References

  • Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med.163(9), 1009–1021 (2003).
  • World Health Organization. Global tuberculosis control. Surveillance, Planning, Financing. WHO Report 2005. World Health Organization, Geneva, Switzerland, 1–247 (2005).
  • Foulds J, O’Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int. J. Tuberc. Lung Dis.2(10), 778–783 (1998).
  • Perkins MD. New diagnostic tools for tuberculosis. Int. J. Tuberc. Lung Dis.4(12 Suppl. 2), S182–S188 (2000).
  • Perkins MD, Small PM. Admitting defeat. Int. J. Tuberc. Lung Dis.10(1), 1 (2006).
  • Fisher M. Diagnosis of MDR-TB: a developing world problem on a developed world budget. Expert Rev. Mol. Diagn.2(2), 151–159 (2002).
  • Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin. Chest Med.26(2), 247–271, vi (2005).
  • Pai M. The accuracy and reliability of nucleic acid amplification tests in the diagnosis of tuberculosis. Natl Med. J. India17(5), 233–236 (2004).
  • American Thoracic Society. Rapid diagnostic tests for tuberculosis: what is the appropriate use? American Thoracic Society Workshop. Am. J. Respir. Crit. Care Med.155(5), 1804–1814 (1997).
  • Flores LL, Pai M, Colford JM Jr, Riley LW. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol.5, 55 (2005).
  • Pai M, Flores LL, Hubbard A, Riley LW, Colford JM Jr. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect. Dis.4(1), 6 (2004).
  • Pai M, Flores LL, Pai N et al. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect. Dis.3(10), 633–643 (2003).
  • Piersimoni C, Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J. Clin. Microbiol.41(12), 5355–5365 (2003).
  • Sarmiento OL, Weigle KA, Alexander J, Weber DJ, Miller WC. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J. Clin. Microbiol.41(7), 3233–3240 (2003).
  • Iwamoto T, Sonobe T, Hayashi K. Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J. Clin. Microbiol.41(6), 2616–2622 (2003).
  • Gennaro ML. Immunologic diagnosis of tuberculosis. Clin. Infect. Dis.30(Suppl. 3), S243–S246 (2000).
  • Daniel TM. Antibody and antigen detection for the immunodiagnosis of tuberculosis: why not? What more is needed? Where do we stand today? J. Infect. Dis.158(4), 678–680 (1988).
  • Bothamley GH. Serological diagnosis of tuberculosis. Eur. Respir. J. Suppl.20, 676s–688s (1995).
  • Chan ED, Heifets L, Iseman MD. Immunologic diagnosis of tuberculosis: a review. Tuber. Lung Dis.80(3), 131–140 (2000).
  • Laal S, Skeiky YAW. Immune-based methods. In: Tuberculosis and the Tubercle Bacillus. Cole ST, Eisenach KD, McMurray DN, Jacobs WR Jr (Eds), ASM Press, DC, USA, 71–83 (2005).
  • Davidow A, Kanaujia GV, Shi L et al. Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect. Immun.73(10), 6846–6851 (2005).
  • Gennaro ML. Serologic tests for TB: is there hope? Int. J. Tuberc. Lung Dis.9(11), S18 (2005).
  • Pereira Arias-Bouda LM, Nguyen LN, Ho LM et al. Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J. Clin. Microbiol.38(6), 2278–2283 (2000).
  • Boehme C, Molokova E, Minja F et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans. R Soc. Trop. Med. Hyg.99(12), 893–900 (2005).
  • Harboe M, Nagai S, Patarroyo ME et al. Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG. Infect. Immun.52(1), 293–302 (1986).
  • Nakamura RM, Velmonte MA, Kawajiri K et al. MPB64 mycobacterial antigen: a new skin-test reagent through patch method for rapid diagnosis of active tuberculosis. Int. J. Tuberc. Lung Dis.2(7), 541–546 (1998).
  • Nakamura RM, Einck L, Velmonte MA et al. Detection of active tuberculosis by an MPB-64 transdermal patch: a field study. Scand. J. Infect. Dis.33(6), 405–407 (2001).
  • Geisbrecht BV, Nikonenko B, Samala R et al. Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosis. Protein Expr. Purif.46, 64–72 (2006).
  • Baylan O, Kisa O, Albay A, Doganci L. Evaluation of a new automated, rapid, colorimetric culture system using solid medium for laboratory diagnosis of tuberculosis and determination of anti-tuberculosis drug susceptibility. Int. J. Tuberc. Lung Dis.8(6), 772–777 (2004).
  • Kocagoz T, O’Brien R, Perkins M. A new colorimetric culture system for the diagnosis of tuberculosis. Int. J. Tuberc. Lung Dis.8(12), 1512; author reply 1513 (2004).
  • Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis.5, 62 (2005).
  • Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol.43(8), 3699–3703 (2005).
  • Makinen J, Marttila HJ, Marjamaki M, Viljanen MK, Soini H. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol.44(2), 350–352 (2006).
  • Kalantri S, Pai M, Pascopella L, Riley L, Reingold A. Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta-analysis. BMC Infect. Dis.5(1), 59 (2005).
  • Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J. Infect.51(3), 175–187 (2005).
  • Wilson SM, al-Suwaidi Z, McNerney R, Porter J, Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis. Nature Med.3(4), 465–468 (1997).
  • Jacobs WR Jr, Barletta RG, Udani R et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science260(5109), 819–822 (1993).
  • Mole RJ, Trollip AP, Seaman T, Abrahams C, Albert H. Improved contamination control using a new antimicrobial supplement developed for rapid phage-based rifampicin susceptibility testing. Int. J. Tuberc. Lung Dis.9(11 Suppl. 1), S271 (2005).
  • Guerra H, Rojas G, Chauca J et al. Evaluation of a phage amplification assay for detection of MDR-TB in smear-positive patients in Lima, Peru (preliminary report). Int. J. Tuberc. Lung Dis.9(11 Suppl. 1), S196 (2005).
  • Riska PF, Su Y, Bardarov S et al. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx box. J. Clin. Microbiol.37(4), 1144–1149 (1999).
  • Hazbon MH, Guarin N, Ferro BE et al. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol.41(10), 4865–4869 (2003).
  • El-Hajj HH, Marras SA, Tyagi S, Kramer FR, Alland D. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J. Clin. Microbiol.39(11), 4131–4137 (2001).
  • Lin SYG, Probert W, Lo M, Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J. Clin. Microbiol.42(9), 4204–4208 (2004).
  • Piatek AS, Telenti A, Murray MR et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother.44(1), 103–110 (2000).
  • Varma-Basil M, El-Hajj H, Colangeli R et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J. Clin. Microbiol.42(12), 5512–5516 (2004).
  • Lin SYG, Mase S, Desmond E et al. Utilization of molecular beacons for rapid detection of MDR-TB in a public health setting. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, DC, USA, (2005).
  • Caviedes L, Lee TS, Gilman RH et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J. Clin. Microbiol.38(3), 1203–1208 (2000).
  • Moore DA, Mendoza D, Gilman RH et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J. Clin. Microbiol.42(10), 4432–4437 (2004).
  • Small PM, Perkins MD. More rigour needed in trials of new diagnostic agents for tuberculosis. Lancet356(9235), 1048–1049 (2000).
  • Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc. Am. Thorac. Soc.3, 103–110 (2006).
  • Perkins MD, Roscigno G, Zumla A. Progress towards improved tuberculosis diagnostics for developing countries. Lancet367, 942–943 (2006).

Websites

  • Stop TB Working Group on New Diagnostics www.stoptb.org/wg/new_diagnostics
  • Foundation for Innovative New Diagnostics www.finddiagnostics.org
  • Tuberculosis Diagnostics Initiative, Special Programme for Research and Training in Tropical Diseases, WHO www.who.int/tdr/diseases/tb/tbdi.htm
  • Aeras Global TB Vaccine Foundation www.aeras.org
  • Global Alliance for Tuberculosis Drug Development www.tballiance.org
  • Gen-Probe Inc. www.gen-probe.com
  • Roche Diagnostics www.roche-diagnostics.com
  • Becton Dickinson www.bd.com
  • Eiken Genome Site http://loopamp.eiken.co.jp/e/index.html
  • Sequella, Inc. http://sequella.com
  • Salubris, Inc. www.salubrisinc.com
  • Innogenetics NV www.innogenetics.com
  • Hain Lifescience GmbH www.hain-lifescience.de
  • Biotec Laboratories Ltd www.biotec.com
  • Molecular Beacons, Public Health Research Institute www.molecular-beacons.org
  • Global Plan to Stop TB, 2006–2015 www.stoptb.org/globalplan

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.